Figure 8 demonstrates the potential of technologies to create mature insulin-producing organoids for transplantation in T1DM patients. Table 2 summarizes the advantages and disadvantages of the three main approaches to control or cure T1DM covered in this review. This evidence concerns the gene INS and type 1 diabetes mellitus.